Statistics
Publications
25
Citations
797
H-Index
18
Active since
2002
Yingchun Hou is an author at Shaanxi Normal University specializing in oncology, medicine, and molecular oncology.
Publications per year
2002–2023
25
25
The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells
Wang Yin, Dongxi Xiang, Tao Wang et al. · Scientific Reports · 2021 · 93 citations · Full text
Medicine, Oncology, Pharmacology +16
Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
Dongxi Xiang, Sarah Shigdar, Andrew G. D. Bean et al. · Theranostics · 2017 · 91 citations · Full text
Medicine, Oncology, Pharmacology +17
Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
Hadi AlShamaileh, Tao Wang, Dongxi Xiang et al. · Scientific Reports · 2017 · 49 citations · Full text
Medicine, Oncology, Pharmacology +17
Xinan Jiao, Takashi Hirano, Yingchun Hou et al. · Infection and Immunity · 2002 · 44 citations · Full text
1–5 of 25